Shares of Fresenius Medical Care AG (ETR:FME – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of €45.64 ($53.07) and traded as low as €45.27 ($52.64). Fresenius Medical Care shares last traded at €45.72 ($53.16), with a volume of 239,109 shares.
Fresenius Medical Care Stock Performance
The firm has a market capitalization of $13.67 billion, a PE ratio of 20.75, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The company has a debt-to-equity ratio of 82.24, a quick ratio of 0.80 and a current ratio of 1.37. The company’s fifty day moving average price is €43.16 and its two-hundred day moving average price is €45.64.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Stories
- Five stocks we like better than Fresenius Medical Care
- What Investors Need to Know to Beat the Market
- EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector
- Investing in Travel Stocks Benefits
- These Are the 3 Hottest Sectors for Q3 Earnings Growth
- 3 Warren Buffett Stocks to Buy Now
- AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
